PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Direxion Daily S&P Biotech Bull 3x Shares (LABU)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

ETF Info

ISINUS25490K3234
CUSIP25490K323
IssuerDirexion
Inception DateMay 28, 2015
RegionNorth America (U.S.)
CategoryLeveraged Equities, Leveraged
Leveraged3x
Index TrackedS&P Biotechnology Select Industry Index (300%)
Home Pagewww.direxion.com
Asset ClassEquity

Asset Class Size

Multi-Cap

Asset Class Style

Growth

Expense Ratio

LABU has a high expense ratio of 1.12%, indicating higher-than-average management fees.


Expense ratio chart for LABU: current value at 1.12% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%1.12%

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Direxion Daily S&P Biotech Bull 3x Shares

Popular comparisons: LABU vs. XBI, LABU vs. LABD, LABU vs. SOXL, LABU vs. TQQQ, LABU vs. WEBL, LABU vs. UCO, LABU vs. UPRO, LABU vs. QQQ, LABU vs. SPY, LABU vs. COIN

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Direxion Daily S&P Biotech Bull 3x Shares, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%100.00%150.00%December2024FebruaryMarchAprilMay
-96.66%
138.79%
LABU (Direxion Daily S&P Biotech Bull 3x Shares)
Benchmark (^GSPC)

S&P 500

Returns By Period

Direxion Daily S&P Biotech Bull 3x Shares had a return of -15.45% year-to-date (YTD) and -16.52% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-15.45%6.17%
1 month-10.49%-2.72%
6 months74.56%17.29%
1 year-16.52%23.80%
5 years (annualized)-36.60%11.47%
10 years (annualized)N/A10.41%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-8.52%35.81%-12.31%-31.53%
2023-28.61%41.91%58.33%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of LABU is 17, indicating that it is in the bottom 17% of the market in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of LABU is 1717
Direxion Daily S&P Biotech Bull 3x Shares(LABU)
The Sharpe Ratio Rank of LABU is 1414Sharpe Ratio Rank
The Sortino Ratio Rank of LABU is 2424Sortino Ratio Rank
The Omega Ratio Rank of LABU is 2222Omega Ratio Rank
The Calmar Ratio Rank of LABU is 1212Calmar Ratio Rank
The Martin Ratio Rank of LABU is 1313Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Direxion Daily S&P Biotech Bull 3x Shares (LABU) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


LABU
Sharpe ratio
The chart of Sharpe ratio for LABU, currently valued at -0.06, compared to the broader market-1.000.001.002.003.004.005.00-0.06
Sortino ratio
The chart of Sortino ratio for LABU, currently valued at 0.52, compared to the broader market-2.000.002.004.006.008.000.52
Omega ratio
The chart of Omega ratio for LABU, currently valued at 1.06, compared to the broader market0.501.001.502.002.501.06
Calmar ratio
The chart of Calmar ratio for LABU, currently valued at -0.05, compared to the broader market0.002.004.006.008.0010.0012.0014.00-0.05
Martin ratio
The chart of Martin ratio for LABU, currently valued at -0.15, compared to the broader market0.0020.0040.0060.0080.00-0.15
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.97, compared to the broader market-1.000.001.002.003.004.005.001.97
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.84, compared to the broader market-2.000.002.004.006.008.002.84
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.34, compared to the broader market0.501.001.502.002.501.34
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.50, compared to the broader market0.002.004.006.008.0010.0012.0014.001.50
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 7.61, compared to the broader market0.0020.0040.0060.0080.007.61

Sharpe Ratio

The current Direxion Daily S&P Biotech Bull 3x Shares Sharpe ratio is -0.06. This value is calculated based on the past 12 months of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Direxion Daily S&P Biotech Bull 3x Shares with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2024FebruaryMarchAprilMay
-0.06
1.97
LABU (Direxion Daily S&P Biotech Bull 3x Shares)
Benchmark (^GSPC)

Dividends

Dividend History

Direxion Daily S&P Biotech Bull 3x Shares granted a 0.57% dividend yield in the last twelve months. The annual payout for that period amounted to $0.58 per share.


PeriodTTM2023202220212020201920182017
Dividend$0.58$0.42$0.00$0.00$0.00$3.27$4.22$2.65

Dividend yield

0.57%0.35%0.00%0.00%0.00%0.28%0.64%0.17%

Monthly Dividends

The table displays the monthly dividend distributions for Direxion Daily S&P Biotech Bull 3x Shares. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2024$0.00$0.00$0.16$0.00
2023$0.00$0.00$0.00$0.00$0.00$0.17$0.00$0.00$0.04$0.00$0.00$0.21
2022$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2021$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2020$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2019$0.00$0.00$2.19$0.00$0.00$0.75$0.00$0.00$0.22$0.00$0.00$0.11
2018$0.00$0.00$0.00$0.00$0.00$0.39$0.00$0.00$1.91$0.00$0.00$1.92
2017$2.65

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2024FebruaryMarchAprilMay
-97.75%
-3.62%
LABU (Direxion Daily S&P Biotech Bull 3x Shares)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Direxion Daily S&P Biotech Bull 3x Shares. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Direxion Daily S&P Biotech Bull 3x Shares was 98.92%, occurring on Oct 27, 2023. The portfolio has not yet recovered.

The current Direxion Daily S&P Biotech Bull 3x Shares drawdown is 97.75%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.92%Jul 20, 20152085Oct 27, 2023
-20.23%Jun 23, 201511Jul 8, 20154Jul 14, 201515
-4.93%Jun 9, 20154Jun 12, 20153Jun 17, 20157
-1.91%Jun 4, 20151Jun 4, 20151Jun 5, 20152
-0.95%Jun 2, 20151Jun 2, 20151Jun 3, 20152

Volatility

Volatility Chart

The current Direxion Daily S&P Biotech Bull 3x Shares volatility is 24.27%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%30.00%35.00%December2024FebruaryMarchAprilMay
24.27%
4.05%
LABU (Direxion Daily S&P Biotech Bull 3x Shares)
Benchmark (^GSPC)